PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
35.86
+0.43 (1.21%)
At close: Dec 5, 2025, 4:00 PM EST
35.89
+0.03 (0.08%)
After-hours: Dec 5, 2025, 7:09 PM EST
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for PROCEPT BioRobotics stock ranges from a low of $50 to a high of $84. The average analyst price target of $56.57 forecasts a 57.75% increase in the stock price over the next year.
Price Target: $56.57 (+57.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $56 → $51 | Buy | Maintains | $56 → $51 | +42.22% | Dec 2, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $85 → $50 | Strong Buy | Maintains | $85 → $50 | +39.43% | Nov 5, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $55 → $50 | Buy | Reiterates | $55 → $50 | +39.43% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $58 → $51 | Buy | Maintains | $58 → $51 | +42.22% | Nov 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $64 → $50 | Strong Buy | Maintains | $64 → $50 | +39.43% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
333.01M
from 224.50M
Increased by 48.34%
Revenue Next Year
430.76M
from 333.01M
Increased by 29.35%
EPS This Year
-1.54
from -1.75
EPS Next Year
-1.17
from -1.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 355.4M | 454.7M | ||||
| Avg | 333.0M | 430.8M | ||||
| Low | 318.0M | 406.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 58.3% | 36.5% | ||||
| Avg | 48.3% | 29.4% | ||||
| Low | 41.6% | 22.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.54 | -0.55 | ||||
| Avg | -1.54 | -1.17 | ||||
| Low | -1.51 | -1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.